Literature DB >> 29463726

Structures of the prefusion form of measles virus fusion protein in complex with inhibitors.

Takao Hashiguchi1, Yoshinari Fukuda2, Rei Matsuoka3,4, Daisuke Kuroda5, Marie Kubota2, Yuta Shirogane2, Shumpei Watanabe2, Kouhei Tsumoto5,6, Daisuke Kohda3, Richard Karl Plemper7, Yusuke Yanagi1.   

Abstract

Measles virus (MeV), a major cause of childhood morbidity and mortality, is highly immunotropic and one of the most contagious pathogens. MeV may establish, albeit rarely, persistent infection in the central nervous system, causing fatal and intractable neurodegenerative diseases such as subacute sclerosing panencephalitis and measles inclusion body encephalitis. Recent studies have suggested that particular substitutions in the MeV fusion (F) protein are involved in the pathogenesis by destabilizing the F protein and endowing it with hyperfusogenicity. Here we show the crystal structures of the prefusion MeV-F alone and in complex with the small compound AS-48 or a fusion inhibitor peptide. Notably, these independently developed inhibitors bind the same hydrophobic pocket located at the region connecting the head and stalk of MeV-F, where a number of substitutions in MeV isolates from neurodegenerative diseases are also localized. Since these inhibitors could suppress membrane fusion mediated by most of the hyperfusogenic MeV-F mutants, the development of more effective inhibitors based on the structures may be warranted to treat MeV-induced neurodegenerative diseases.

Entities:  

Keywords:  fusion; infection; measles virus; neurodegenerative disease; structure

Mesh:

Substances:

Year:  2018        PMID: 29463726      PMCID: PMC5877970          DOI: 10.1073/pnas.1718957115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  66 in total

1.  Evolutionary profiles derived from the QR factorization of multiple structural alignments gives an economy of information.

Authors:  Patrick O'Donoghue; Zaida Luthey-Schulten
Journal:  J Mol Biol       Date:  2005-01-22       Impact factor: 5.469

2.  PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta.

Authors:  Sidhartha Chaudhury; Sergey Lyskov; Jeffrey J Gray
Journal:  Bioinformatics       Date:  2010-01-07       Impact factor: 6.937

3.  Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol.

Authors:  Rameshwar U Kadam; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-21       Impact factor: 11.205

4.  Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology.

Authors:  Shumpei Watanabe; Shinji Ohno; Yuta Shirogane; Satoshi O Suzuki; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

5.  Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.

Authors:  William J Bellini; Jennifer S Rota; Luis E Lowe; Russell S Katz; Paul R Dyken; Sherif R Zaki; Wun-Ju Shieh; Paul A Rota
Journal:  J Infect Dis       Date:  2005-10-12       Impact factor: 5.226

6.  MAFFT multiple sequence alignment software version 7: improvements in performance and usability.

Authors:  Kazutaka Katoh; Daron M Standley
Journal:  Mol Biol Evol       Date:  2013-01-16       Impact factor: 16.240

7.  Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters.

Authors:  Shumpei Watanabe; Yuta Shirogane; Satoshi O Suzuki; Satoshi Ikegame; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

8.  Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody.

Authors:  Jason S McLellan; Man Chen; Sherman Leung; Kevin W Graepel; Xiulian Du; Yongping Yang; Tongqing Zhou; Ulrich Baxa; Etsuko Yasuda; Tim Beaumont; Azad Kumar; Kayvon Modjarrad; Zizheng Zheng; Min Zhao; Ningshao Xia; Peter D Kwong; Barney S Graham
Journal:  Science       Date:  2013-04-25       Impact factor: 47.728

9.  Characterization of naturally occurring parainfluenza virus type 2 (hPIV-2) variants.

Authors:  O Terrier; G Cartet; O Ferraris; F Morfin; D Thouvenot; S S Hong; B Lina
Journal:  J Clin Virol       Date:  2008-06-25       Impact factor: 3.168

10.  Structural basis for antibody-mediated neutralization of Lassa virus.

Authors:  Kathryn M Hastie; Michelle A Zandonatti; Lara M Kleinfelter; Megan L Heinrich; Megan M Rowland; Kartik Chandran; Luis M Branco; James E Robinson; Robert F Garry; Erica Ollmann Saphire
Journal:  Science       Date:  2017-06-02       Impact factor: 47.728

View more
  24 in total

1.  Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.

Authors:  Venice Du Pont; Christoph Wirblich; Jeong-Joong Yoon; Robert M Cox; Matthias J Schnell; Richard K Plemper
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Weak cis and trans Interactions of the Hemagglutinin with Receptors Trigger Fusion Proteins of Neuropathogenic Measles Virus Isolates.

Authors:  Yuta Shirogane; Takao Hashiguchi; Yusuke Yanagi
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

3.  Self-assembly Stability Compromises the Efficacy of Tryptophan-Containing Designed Anti-measles Virus Peptides.

Authors:  Diogo A Mendonça; Tiago N Figueira; Manuel N Melo; Olivia Harder; Stefan Niewiesk; Anne Moscona; Matteo Porotto; Ana Salomé Veiga
Journal:  J Nanomed Nanotechnol       Date:  2019-03-12

Review 4.  Receptor-mediated cell entry of paramyxoviruses: Mechanisms, and consequences for tropism and pathogenesis.

Authors:  Chanakha K Navaratnarajah; Alex R Generous; Iris Yousaf; Roberto Cattaneo
Journal:  J Biol Chem       Date:  2020-01-16       Impact factor: 5.157

5.  Measles Virus Bearing Measles Inclusion Body Encephalitis-Derived Fusion Protein Is Pathogenic after Infection via the Respiratory Route.

Authors:  Cyrille Mathieu; Marion Ferren; Eric Jurgens; Claire Dumont; Ksenia Rybkina; Olivia Harder; Debora Stelitano; Silvia Madeddu; Giuseppina Sanna; Dayna Schwartz; Sudipta Biswas; Diana Hardie; Takao Hashiguchi; Anne Moscona; Branka Horvat; Stefan Niewiesk; Matteo Porotto
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

6.  Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain.

Authors:  Fabrizio Angius; Heidi Smuts; Ksenia Rybkina; Debora Stelitano; Brian Eley; Jo Wilmshurst; Marion Ferren; Alexandre Lalande; Cyrille Mathieu; Anne Moscona; Branka Horvat; Takao Hashiguchi; Matteo Porotto; Diana Hardie
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 7.  Measles Resurgence and Drug Development.

Authors:  Richard K Plemper
Journal:  Curr Opin Virol       Date:  2020-04-01       Impact factor: 7.090

8.  Fitness selection of hyperfusogenic measles virus F proteins associated with neuropathogenic phenotypes.

Authors:  Satoshi Ikegame; Takao Hashiguchi; Chuan-Tien Hung; Kristina Dobrindt; Kristen J Brennand; Makoto Takeda; Benhur Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

9.  CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Acting in cis.

Authors:  Yuta Shirogane; Ryuichi Takemoto; Tateki Suzuki; Tomonori Kameda; Kinichi Nakashima; Takao Hashiguchi; Yusuke Yanagi
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

Review 10.  Small-Molecule Inhibition of Viral Fusion Glycoproteins.

Authors:  Han-Yuan Liu; Priscilla L Yang
Journal:  Annu Rev Virol       Date:  2021-07-01       Impact factor: 10.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.